PET/CT with fluorine-18-fluorodeoxyglucose (18F-FDG), the most commonly used radiotracer for PET neuroimaging and cancer patient management, is effective for differentiating between tumors, metastases and lymphomas in the brain and central nervous system, according to a study conducted in India and published online Sept. 15 in Nuclear Medicine Communications. {read more here}

This development may improve treatment of patients with suspicious lung cancers, especially in advanced cases. The new findings also hold promise for development of a noninvasive method of accurately determining the type of lung lesions. {read more here}

A new and particularly reliable method for marking cells can simplify research into diseases such as myocardial infarction, diabetes or Alzheimer’s and reduce the use of test animals: Scientists from the University of Tübingen have developed a method by which they can target specific cell types in mice and monitor their behavior using positron emission tomography (PET). PET-based cell tracking allows scientists to observe complex life processes in the body without subjecting test animals to invasive methods. {read more here}

French researchers are alerting radiology facilities to an incident that occurred in their PET/MRI suite: Copper fibers in a blanket used to cover a patient began to heat up, causing the blanket to smolder and nearly catch fire, according to a case study published August 31 in Radiology. {read more here}